Identification of Key Small Non-Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• The sinus node (SN) is the heart's primary pacemaker, with unique ion channel and Ca2+-handling protein expression.
• MicroRNAs (miRs) regulate gene expression, but their role in human SN pacemaking and conduction is unexplored.

Purpose of the Study:

• To determine the miR expression profile of the human SN compared to non-pacemaker atrial muscle.
• To identify miRs controlling genes essential for SN pacemaking.

Main Methods:

• Human SN and atrial muscle biopsies analyzed using histology, immunolabeling, and TaqMan Human MicroRNA Arrays (754 miRs).
• Ingenuity Pathway Analysis identified miRs targeting SN pacemaker genes.
• Luciferase reporter gene assay validated miR-486-3p's control over HCN4 expression.

Main Results:

• Significant differences in miR abundance between SN and atrial muscle (18 more, 48 less abundant in SN).
• miR-486-3p was predicted to inhibit pacemaking channels (HCN1, HCN4, Cav1.3, Cav3.1).
• miR-486-3p transfection in ex vivo SN preparations reduced beating rate by ~35% and HCN4 expression.

Conclusions:

• The human SN exhibits a unique miR expression pattern targeting functionally important genes.
• miR-486-3p plays a crucial role in SN pacemaker activity by targeting HCN4.
• miR-486-3p represents a potential therapeutic target for sinus node diseases like sinus tachycardia.